Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
Open Access
- 1 September 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9) , 2727-2734
- https://doi.org/10.1128/aac.46.9.2727-2734.2002
Abstract
Resistance to erythromycin in Streptococcus pneumoniae was first detected in 1967 in the United States and subsequently worldwide ([11][1], [20][2]). The corresponding mechanism was rapidly identified as ribosomal methylation, which had been primarily reported as being responsible for erythromycinThis publication has 51 references indexed in Scilit:
- Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and StaphylococciAntimicrobial Agents and Chemotherapy, 2002
- Emergence of Macrolide Resistance during Treatment of Pneumococcal PneumoniaNew England Journal of Medicine, 2002
- Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European CountriesAntimicrobial Agents and Chemotherapy, 2002
- Serotype 19F Multiresistant Pneumococcal Clone Harboring Two Erythromycin Resistance Determinants [ erm (B) and mef (A)] in South AfricaAntimicrobial Agents and Chemotherapy, 2001
- The Structural Basis of Ribosome Activity in Peptide Bond SynthesisScience, 2000
- The Complete Atomic Structure of the Large Ribosomal Subunit at 2.4 Å ResolutionScience, 2000
- Induction of Ribosome Methylation in MLS-ResistantStreptococcus pneumoniaeby Macrolides and KetolidesMicrobial Drug Resistance, 1999
- The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistanceStructure, 1998
- Characterization of a new β-lactamase from Fusobacterium nucleatum by substrate profiles and chromatofocusing patternsJournal of Antimicrobial Chemotherapy, 1985
- PNEUMOCOCCUS RESISTANT TO ERYTHROMYCIN AND LINCOMYCINThe Lancet, 1967